Palantir Technologies (NASDAQ: PLTR) entered the final days of April 2026 carrying a paradox that had been frustrating both its bulls and its critics for months: the company had just reported the strongest quarter in its history, and the stock had fallen 31% from its peak anyway.
PLTR hit a 52-week high of $207.52 in February 2026, immediately after Q4 2025 results that CEO Alexander Karp described in a CNBC interview as “indisputably the best results I’m aware of in tech in the last decade.” Revenue for the quarter came in at $1.407 billion, up 70% year-on-year. US commercial revenue surged 137% to $507 million. US government revenue grew 66% to $570 million. Total contract value hit a record $4.262 billion, up 138% year-on-year.
By late April, the stock had retreated to around $142 to $143. The decline had nothing to do with deteriorating fundamentals. It had everything to do with valuation compression across the high-multiple software sector, broader selloffs following earnings disappointments at other enterprise software names, and profit-taking after a cumulative three-year run of more than 1,600%.
At a forward price-to-earnings multiple of around 108x to 111x, PLTR never had much margin for error. Analyst commentary describing the stock as priced for perfection at euphoric and unsustainable levels rattled confidence in the valuation, even as the underlying business continued to print exceptional numbers.
The next binary event is Q1 2026 earnings on May 4. Consensus revenue guidance sits at $1.532 billion to $1.536 billion, implying approximately 74% year-on-year growth. Analysts are forecasting adjusted EPS of $0.28, more than double the $0.13 the company delivered in Q1 2025. For the full year, management had guided for revenue of $7.182 billion to $7.198 billion, implying 61% growth, and Wall Street analysts are projecting earnings of approximately $1.05 per share for 2026, a projected 67% year-on-year increase.
The Seeking Alpha piece that framed PLTR as a potential nibble ahead of earnings captured the mood among cautiously optimistic investors reasonably well. After a 31% drawdown, the risk-reward had shifted. The stock was not cheap by any conventional measure, but it was materially cheaper than it had been when euphoria peaked in February.
The case for buying into earnings rests on execution. If US commercial revenue sustains growth above 100% year-on-year and quarterly total contract value bookings hold above $1 billion, the argument that this drawdown was a healthy reset rather than a structural peak remains intact. If growth shows any sign of deceleration, even a modest one, the multiple will make that very expensive to absorb.
PLTR had delivered beats in the previous several quarters, with an average EPS surprise of roughly 8% to 10% over the three quarters before a slight Q4 2025 miss. The May 4 print is the first real test of whether the government and commercial AI momentum has been maintained through the start of 2026, or whether the stock’s retreat was signalling something the numbers had not yet confirmed.
